FDA Seeks Feedback on Research Plan on ‘Targeted’ Mechanism of Action Ads

The FDA’s Office of Prescription Drug Promotion (OPDP) is aiming to understand how “targeted” mechanism of action (MoA) advertising affects how healthcare workers and consumers view a drug and is soliciting public comment on its research proposal.
Source: Drug Industry Daily